medigraphic.com
ISSN 1405-1710 (Print)

2000, Number 2

<< Back Next >>

Rev Cent Dermatol Pascua 2000; 9 (2)

Graft versus host disease

Beirana PA, Alcalá PD, Franco CA

Language: Spanish
References: 20
Page: 74-80
PDF size: 55.56 Kb.


ABSTRACT

Graft versus host disease is a clinical syndrome characterized by cutaneous changes, liver and gastrointestinal dysfunction. Within the cutaneous manifestations four grades have been described, toxic epidermal necrolysis being the worst of them. This is a brief review of this topic.


REFERENCES

  1. Jones M, Sols M, Fraga J. Necrólisis epidérmica tóxica como manifestación de enfermedad injerto contra huésped cutánea grado IV. Actas Dermo Sif 1992; 83: 13-16.

  2. Farmer ER, Hood AF. Graft versus host disease. In: Fitzpatrick, Eisen, Wolff et al. Dermatology in General Medicine. 4ª edición 1993;2:1510-1518.

  3. Abbas AK, Lishtman A, Pober J. Respuestas inmunitarias a los trasplantes celulares. In: Abbas, Lishtman, Pober. Inmunología Celular y Molecular. 2ª edición Madrid, España: Interamericana 1995: 379-398.

  4. Ferrara LM, Deeg HJ. Graft-versus Host Disease. N Engl J Med 1991; 324: 667-674.

  5. Horn TD. Graft versus Host Disease. In: Arndt, Le Boid, Robinson et al. Cutaneous Medicine and Surgery. 1ª edición W.B. Saunders Company 1996;1:225-234.

  6. Rowel NR, Goodfield MJ. Collagen Tissue Disorders. In: Rook, Wilkinson, Ebling. Textbook of Dermatology. 5ª edición Oxford: Blackwell Scientific Publications 1992; 3: 2238-2240.

  7. Roitt I, Brostoff J, Male D. Trasplante y rechazo. In: Roitt, Brostoff, Male. Inmunología. 4ª edición Madrid, España: Harcourt Brace 1997: 26.1-26.13.

  8. Aractingi S, Chosidow O. Cutaneous Graft-versus-host disease. Arch Dermatol 1998; 134: 602-612.

  9. Langley RG, Walsh MD, Nevill Th et al. Apoptosis is the mode of keratinocyte death in cutaneous graft-versus-host disease. J Am Acad Dermatol 1996; 35: 187-190.

  10. Takeda H, Mitsuhashi Y, Kondo S. Toxic epidermal necrolysis possibly linked to hyperacute graft- versus -host disease after allogenic bone marrow transplantation. J Dermatol 1997; 21: 635-641.

  11. Martin RW, Farmer ER, Altomonte AL et al. Lichenoid graft-vs-host-disease in an autologous bone marrow transplant recipient. Arch Dermatol 1995; 131: 333-335.

  12. Liddle BJ, Cowan MA. Lichen planus-like eruption and nail changes in a patient with graft-versus-host disease. Br J Dermatol 1990; 122: 841-843.

  13. Ollivier I, Wolkenstein PW, Gherardi R et al. Dermatomyositis-like graft-versus-host disease. Br J Dermatol 1998; 138: 558-559.

  14. Nagler A, Goldenhersh MA, Levi-Schaffer F et al. Total leucoderma: a rare manifestation of cutaneous chronic graft-versus-host disease. Br J Dermatol 1996; 134: 780-783.

  15. Hideyuki T, Yamakage A, Yamazaki S. Electron-microscopic study of sclerodermatous chronic graft-versus-host disease. Int J Dermatol 1996; 35: 862-866.

  16. Barnadas MA, Moreno A, Brunet S et al. Enfermedad de injerto contra huésped. Estudio histopatológico prospectivo. Actas Dermo Sif 1993; 84: 1-5.

  17. Woscoff A, Ruíz Lazcano A, De Pablo A, Robinson A. Sclerodermatous changes of chronic graft-versus-host diseases treated with PUVA. Int J Dermatol 1996; 35: 656-658.

  18. Darmstadt GL, Donnenberg AD, Vogelsang GB et al. Clinical, Laboratory, and Histopathologic Indicators of the Development of Progressive Acute Graft-Versus-Host Disease. J Invest Dermatol 1992; 99: 397-401.

  19. Collins RH, Cooper B, Nikaein A. Graft-versus-host disease in a liver transplant recipient. Ann Int Med 1992; 116: 392.

  20. Redondo P, España A, Herrero JI et al. Graft-versus-host disease after liver transplantation. J Am Acad Dermatol 1993; 29: 314-317.




2020     |     www.medigraphic.com